Robert Janssen, MD
Dynavax Technologies Corporation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert Janssen, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:00 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05506969 · Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of AgeDynavax Technologies Corporation · completed · Plague, Pneumonic, Plague, Vaccine-Preventable Diseases · study chair
- Ph1NCT05245838 · Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult VolunteersDynavax Technologies Corporation · completed · Shingles, Herpes Zoster, Vaccine-Preventable Diseases · study chair
- Ph1NCT03934736 · HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing HemodialysisDynavax Technologies Corporation · completed · End Stage Renal Disease on Hemodialysis (Diagnosis) · study chair
- Ph3NCT02117934 · Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® VaccineDynavax Technologies Corporation · completed · Healthy · study director
- Ph1NCT01999699 · A Study of the Immune Response to Heplisav in Healthy Older AdultsDynavax Technologies Corporation · completed · Hepatitis B · study director
- Ph3NCT00985426 · Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) PatientsDynavax Technologies Corporation · completed · Chronic Kidney Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 8 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.